Redwood Investments, LLC Bio N Tech Se Transaction History

Redwood Investments, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$122.57 - $153.67 $333,267 - $417,828	2,719 Added 3.11%	90,259 $11.2 Million
Q4 2022 Jan 20, 2023	BUY	$118.43 - $186.05 $3.94 Million - $6.19 Million	33,294 Added 61.38%	87,540 $0
Q3 2022 Oct 28, 2022	BUY	$127.65 - $183.11 $12,765 - $18,311	100 Added 0.18%	54,246 $7.32 Million
Q2 2022 Jul 15, 2022	BUY	$123.25 - $186.24 $1.87 Million - $2.83 Million	15,212 Added 39.07%	54,146 $8.07 Million
Q1 2022 Apr 20, 2022	BUY	$126.25 - $231.85 $1.66 Million - $3.05 Million	13,145 Added 50.97%	38,934 $6.64 Million
Q4 2021 Feb 03, 2022	SELL	$216.64 - $362.52 $3,899 - $6,525	-18 Reduced 0.07%	25,789 $6.65 Million
Q3 2021 Oct 19, 2021	SELL	$205.93 - $447.23 $108,113 - $234,795	-525 Reduced 1.99%	25,807 $7.05 Million
Q2 2021 Aug 02, 2021	SELL	$113.32 - $241.49 $5.13 Million - $10.9 Million	-45,280 Reduced 63.23%	26,332 $5.9 Million
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $911,652 - $1.27 Million	-10,634 Reduced 12.93%	71,612 $7.82 Million
Q4 2020 Feb 05, 2021	BUY	$72.71 - $129.54 $5.98 Million - $10.7 Million	82,246 New	82,246 $6.71 Million

328

40.6M

845K

1.23M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Investments, LLC with notifications on news.